In vitro studies of the hyperthermic enhancement of activated ifosfamide (4-hydroperoxy-ifosfamide) and glucose isophosphoramide mustard

Cancer Chemotherapy and Pharmacology

Volumn 40, Issue 2, 1997, Pages 167-171

  Kutz, Matthew E ^a   Mulkerin, Daniel L ^a   Wiedemann, Günter J ^b   Katschinski, Dörthe M ^a   Robins, H Ian ^a,c  

^a University of Wisconsin Health   (United States)

^b UNIVERSITY OF LÜBECK   (Germany)

^c UNIVERSITY OF WISCONSIN   (United States)

Author keywords

Chemotherapy; Ifosfamide; Whole body hyperthermia

Indexed keywords

4 HYDROPEROXYIFOSFAMIDE; CYCLOPHOSPHAMIDE DERIVATIVE; D 18851; GLUCOSE ISOPHOSPHORAMIDE; GLUFOSFAMIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL LINE; CELL SURVIVAL; CHEMOTHERAPY; CONTROLLED STUDY; CYTOTOXICITY; FIBROSARCOMA; HUMAN; HUMAN CELL; HYPERTHERMIA; IN VITRO STUDY; NONHUMAN; OVARY ADENOCARCINOMA; PRIORITY JOURNAL; TEMPERATURE;

ANTINEOPLASTIC AGENTS; CELL SURVIVAL; GLUCOSE; HUMANS; HYPERTHERMIA, INDUCED; IFOSFAMIDE; TUMOR CELLS, CULTURED;

EID: 0030987283     PISSN: 03445704     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002800050642     Document Type: Article

References (14)

1. Cohen JD, Robins HI (1990) Thermal enhancement of tetraplatin and carboplatin in human leukemia cells in vitro. Int J Hyperthermia 6: 1013-1017
2. d'Oleire F, Kutz ME, Bird A, Robins HI (1994) Step down heating and melphalan: cytotoxicity interactions and clinical implications. Melanoma Res 4: 303-305
3. Klostergaard J, Leroux E, Siddik ZH, Khodadadian M, Tomasovic SP. (1992) Enhanced sensitivity of human colon tumor cell lines in vitro in response to thermochemoimmunotherapy. Cancer Res 52: 5271-5277
4. Pohl J, Bertram B, Hilgard P, Nowrousian MR, Stuben J, Wiebler M (1995) D19575 - a sugar-linked isophosphoramide mustard derivative exploiting transmembrane glucose transport. Cancer Chemother Pharmacol 35: 364-370
5. Robins HI, Cohen JD, Schmitt CF, Tutsch KD, Feierabend C, Arzoomanian RZ, Alberti D, d'Oleire F, Fongo W, Heiss C, Rushing D, Spriggs D (1993) Phase I clinical trial of carboplatin and 41.8 °C whole body hyperthermia in cancer patients. J Clin Oncol 11: 1787-1794
6. Robins HI, Kutz M, Wiedemann G, Paul D, Katschinski DM, Grosen E, Tiggelaar CL, Spriggs D, Gillis W, d'Oleire F (1995) Cytokine induction by 41.8 °C whole body hyperthermia. Cancer Lett 97: 195-201
7. Schaper M, Bertram B, Stueben J, Pohl J, Wiessler M (1995) Further evidence for a transport of beta-D-glucosyl isophosphoramide mustard (beta-D-Glu-IPM, D-19575) mediated by glucose carriers. Arch Pharmacol 351: R53(Abstr)
8. Wiessler M, Bertram B, Dickes M, Engel J, Hilgard P, Kutscher B, Niemeyer U, Nowrourian MR, Pohl J, Stuehen J, Voegeli R (1994) Glucose-IPM (GLC-IPM, D-19575). A selective chemotherapeutic compound. J Cancer Res Clin Oncol (Suppl)120: R13(Abstr)
9. Wiedemann GJ, Siemens HJ, Mentzel M, Biersack A, Wössmann W, Knocks D, Weiss C, Wagner T (1993) Effects of temperature on the therapeutic efficacy and pharmacokinetics of ifosfamide. Cancer Res 53: 4268-4272
10. Wiedemann GJ, d'Oleire F, Knop E, Eleftheriadis S, Bucsky P, Feddersen S, Klouche M, Geisler J, Mentzel M, Schmucker P, Feyerabend T, Weiss C, Wagner T (1994) Ifosfamide and carboplatin combined with 41.8 °C whole-body hyperthermia in patients with refractory sarcoma and malignant teratoma. Cancer Res 54: 5346-5350
11. Wiedemann GJ, Robins HI, Gutsche S, Mentzel M, Decken M, Katschinski DM, Eleftheriadis S, Crahe R, Weiss C, Storer B, Wagner T (1996) Ifosfamide, carboplatin and etoposide (ICE) combined with 41.8 ° whole-body hyperthermia in patients with refractory sarcoma. Eur J Cancer 32A: 888-892
12. Wiedemann GJ, Robins HI, Katschinski DM, Mentzel M, d'Oleire F, Kutz M, Wagner T (1997) Systemic hyperthermia and ICE chemotherapy for sarcoma patients: rationale and clinical status. Anticancer Res (in press)
13. Wiedemann GJ, Robins HI, Katschinski DM, Mentzel M, van Heek R, Touhidi S, Bucsky P, Gillis W, Feyerabend T, d'Oleire F, Freund C, Eleftheriadis S, Weiss C, Wagner T (1996) Klinische Studien zur Kombination von Ifosfamid. Carboplatin und Etoposide (ICE) mit Ganzkorperhyperthermie. Med Klin 91: 279-283
14. Woods JP, Schmitt CE, Rosenthal RC, d'Oleire F, Robins HI (1995) Canine bone marrow as a potential thermal sanctuary during the plateau phase of 41.8 °C whole body hyperthermia. Int J Hyperthermia 11: 49-57